Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340689 · ClinicalTrials.gov registry record
Primary Hyperoxaluria Mutation Genotyping/Phenotyping
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,235
- Enrollment target
NCT02340689: Completed study, sponsored by Mayo Clinic.
NCT02340689 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1,235 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02340689 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,235 participants
- Enrollment target
Study Summary
Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.
Interventions
- OTHER Genetic Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,235 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02340689
The ClinicalTrials.gov registry entry for NCT02340689 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT02340689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02340689 about?
NCT02340689 is a clinical study titled "Primary Hyperoxaluria Mutation Genotyping/Phenotyping". Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.
What is the current status of trial NCT02340689?
This trial is currently completed. The enrollment target is 1,235 participants. The study started on 2013-10. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02340689?
The interventions under investigation include: Genetic Analysis (OTHER).
Who is sponsoring clinical trial NCT02340689?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.